News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

e-Therapeutics plc Provides Update On ETS2101 Phase I Trial In Brain Cancer



1/7/2014 9:08:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--e-Therapeutics plc today announces that the investigator-led phase I trial of ETS2101 in brain cancer will continue into 2014. Five dose escalation steps have been completed without any drug-related serious adverse events and the investigator therefore intends to enrol further patients at higher dose levels.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES